RPMI-8226/STAT5 Reporter (GFP) stable cell line

RPMI-8226/STAT5 Reporter (GFP) cells are derived from the human myeloma RPMI-8226 cell line by stably integration of a STAT5 GFP reporter construct. The RPMI-8226 cell line is a valuable tool for understanding multiple myeloma and developing new treatments, including CAR-T (chimeric antigen receptor T-cell) therapy. RPMI-8226/STAT5 Reporter (GFP) cells stably express GFP under the control of the STAT5 response elements, can be used for monitoring the activity of STAT5 signaling pathway.